zandelisib
mei,kyowa kirin
['zandelisib', 'mei pharma']
we re pleased to highlight #zandelisib data at this year s #eha2022 hybrid congress: 
We are committed to the development of novel, best-in-class, cancer therapies intended to provide improved outcomes to patients